Phio Pharmaceuticals Corp. Quarterly Operating Income (Loss) in USD from Q3 2011 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Phio Pharmaceuticals Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2011 to Q2 2024.
Phio Pharmaceuticals Corp. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.91M, a 24.9% increase year-over-year.
Phio Pharmaceuticals Corp. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.8M, a 29.3% increase year-over-year.
Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2023 was -$10.8M, a 5.57% increase from 2022.
Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2022 was -$11.5M, a 15.2% increase from 2021.
Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2021 was -$13.5M, a 53.7% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$8.8M	-$1.91M	+$633K	+24.9%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	-$9.43M	-$2.21M	+$1.39M	+38.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$10.8M	-$1.9M	+$831K	+30.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-04-01
Q3 2023	-$11.7M	-$2.78M	+$795K	+22.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	-$12.5M	-$2.55M	-$26K	-1.03%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	-$12.4M	-$3.6M	-$962K	-36.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$11.5M	-$2.73M	+$720K	+20.9%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-01
Q3 2022	-$12.2M	-$3.57M	+$168K	+4.49%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$12.4M	-$2.52M	+$163K	+6.07%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$12.5M	-$2.64M	+$998K	+27.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$13.5M	-$3.45M	-$988K	-40.1%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-22
Q3 2021	-$12.5M	-$3.74M	-$1.43M	-62.1%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	-$11.1M	-$2.68M	-$1.02M	-60.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$10.1M	-$3.64M	-$1.28M	-54.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$8.79M	-$2.46M	+$207K	+7.76%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-22
Q3 2020	-$9M	-$2.31M	-$193K	-9.13%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$8.81M	-$1.67M	+$390K	+18.9%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$9.2M	-$2.36M	-$210K	-9.79%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	-$8.99M	-$2.67M	-$935K	-53.9%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-25
Q3 2019	-$8.05M	-$2.11M	-$621K	-41.6%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-10
Q2 2019	-$7.43M	-$2.06M	-$160K	-8.43%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-12
Q1 2019	-$7.27M	-$2.15M	+$93K	+4.15%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-12
Q4 2018	-$7.36M	-$1.73M	+$257K	+12.9%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-26
Q3 2018	-$7.62M	-$1.49M	+$984K	+39.7%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	-$8.61M	-$1.9M	+$615K	+24.5%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-12
Q1 2018	-$9.22M	-$2.24M	+$4.84M	+68.4%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-14
Q4 2017	-$14.1M	-$1.99M	+$348K	+14.9%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-27
Q3 2017	-$14.4M	-$2.48M	-$260K	-11.7%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	-$14.2M	-$2.51M	-$299K	-13.5%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	-$13.9M	-$7.08M	-$4.84M	-215%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-10
Q4 2016	-$9.02M	-$2.34M	+$283K	+10.8%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-26
Q3 2016	-$9.3M	-$2.22M	+$288K	+11.5%	Jul 1, 2016	Sep 30, 2016	10-Q/A	2018-03-26
Q2 2016	-$9.59M	-$2.22M	-$50K	-2.31%	Apr 1, 2016	Jun 30, 2016	10-Q/A	2018-03-26
Q1 2016	-$9.54M	-$2.25M	+$701K	+23.8%	Jan 1, 2016	Mar 31, 2016	10-Q/A	2018-03-26
Q4 2015	-$10.2M	-$2.62M	-$316K	-13.7%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-30
Q3 2015	-$9.92M	-$2.5M	-$295K	-13.4%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-10
Q2 2015	-$9.63M	-$2.17M	-$144K	-7.13%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-11
Q1 2015	-$9.48M	-$2.95M	-$656K	-28.6%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-12
Q4 2014	-$8.83M	-$2.31M	+$213K	+8.46%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-30
Q3 2014	-$9.04M	-$2.21M	-$138K	-6.66%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-12
Q2 2014	-$8.9M	-$2.02M	-$56K	-2.85%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-12
Q1 2014	-$8.85M	-$2.29M	+$12.1M	+84.1%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-13
Q4 2013	-$20.9M	-$2.52M	-$808K	-47.2%	Oct 1, 2013	Dec 31, 2013	10-K	2015-03-30
Q3 2013	-$20.1M	-$2.07M	-$375K	-22.1%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-13
Q2 2013	-$19.8M	-$1.97M	+$5.7M	+74.4%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-14
Q1 2013	-$25.5M	-$14.4M	-$12.5M	-656%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-14
Q4 2012	-$13M	-$1.71M			Oct 1, 2012	Dec 31, 2012	10-K	2014-03-28
Q3 2012		-$1.7M	+$471K	+21.7%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-14
Q2 2012		-$7.66M			Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-14
Q1 2012		-$1.91M			Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-15
Q3 2011		-$2.17M			Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.